Current stock page

Catalysts

MRK Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareDrug Manufacturers - GeneralScore data as of Oct 21, 2026

MRKMerck & Co., Inc.

Healthcare / Drug Manufacturers - General

Low Priority

Relative Laggard

NeutralEdge 3/10
$149.88+$1.58 (+1.07%)

Latest quote

  • Momentum
    71
  • Value
    27
  • Quality
    47
  • Risk resilience
    44
  • Sentiment
    50
algovestiq.comScore data as of Oct 21, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Oct 29, 2026

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 47/100

Momentum 71/100 and sentiment 50/100 before the next covered event.

Recent coverage
2 articles

Updated Oct 21, 2026 · Sentiment 30.01%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 71/100AIQ Edge 3/10 Relative Laggard
Beat rate
100%
3 of 3 reported periods
Average surprise
+22.1%
Across covered historical reports
Latest result
+51.9%
Aug 4, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Oct 29, 2026—$2.22——$17.32B—
Aug 4, 2026—-$0.27-$0.13+51.9%$16.37B$16.61B
Apr 30, 2026—-$1.47-$1.28+12.9%$15.85B$16.29B
Feb 3, 2026—$2.01$2.04+1.5%$16.2B$16.4B

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
19
Buy
8
Hold
12-month analyst target
$151.86
+1.32% versus current price
Based on 18 analyst observations. Targets are estimates, not predictions.
Low target
$105.00
-29.94% vs latest price
Average target
$151.86
+1.32% vs latest price
High target
$180.00
+20.10% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateOct 29, 2026

Next known earnings or reporting date.

EPS estimate$2.09

Current analyst expectation for the upcoming report.

Revenue estimate$17.29B

Current analyst expectation for the upcoming report.

Sentiment score50

News pressure around the setup.

Momentum score71

Where event reaction would show up first.

AIQ score47/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
18
Average target
$151.86
Target upside
1.32%
Target range
$105.00 - $180.00
90-day revisions
-3

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
1
Neutral
1
Negative
0
insidermonkey.com · Oct 20, 2026

Merck (MRK) Has New Cancer Treatments. Can They Outgrow the Keytruda Patent Cliff?

A Growing Franchise With an Expiration Date Merck & Co., Inc. (NYSE:MRK) is trying to extend its oncology leadership before competition threatens its largest earnings engine.

insidermonkey.com · Oct 19, 2026

Merck’s 2.4% Dividend Yield: A Reliable Income Stream or a Risky Bet on Recovery?

Merck & Co., Inc.

Open full news and sentiment

MRK Catalysts FAQ

What are the next catalysts for MRK stock?

MRK's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move MRK stock?

Upcoming events that could move MRK include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could MRK's next earnings report affect the stock?

MRK's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive MRK stock higher?

MRK could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt MRK stock?

MRK could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.